Navigation Links
Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
Date:9/11/2011

a>)

InteRNA Technologies is a Dutch early-stage drug discovery and development company that develops pathway targeted cancer therapies based on the unique functions of its proprietary microRNAs ("miRNAs").

InteRNA takes an holistic approach in R&D to unravel the biological role of its proprietary miRNAs focusing on the demonstration of their function in a number of cancer indications through functional screens, using its proprietary lentiviral-based miRNA expression library, currently the largest available. This approach results in the identification of novel, "drugable" targets, providing a steady basis for further validation and drug development.

InteRNA Technologies was incorporated in December 2006 by Aglaia Oncology Fund and has established close relationships with the research groups of its founders Edwin Cuppen, PhD, and Eugene Berezikov, PhD, of the Hubrecht Institute (Utrecht, the Netherlands), leading scientific groups in the field of miRNA research. The company further has a series of R&D partnerships with Dutch- and US-based academic hospitals and research institutes.

About MicroRNAs (miRNAs)

MicroRNA (miRNA) are naturally occurring, non-coding strands of RNA that trigger the RNA interference pathway. They result from an extensive processing route in which a long RNA transcript, folded in a hairpin structure, is cleaved into short strands of approximately 22 nucleotides - the miRNA molecules.

MiRNAs regulate gene expression by controlling the efficiency of messenger RNA (mRNA) translation - the process of translating genetic information into proteins. The miRNA binds to its target sequence in mRNA transcripts, leading to translational repression or mRNA degradation. As a result, the production of the protein encoded by that particular mRNA sequence is inhibited.

So far, approximately 940 human miRNA sequences have been documented. For many of these it is not clear what genes they target. How
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
2. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
3. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
4. Silence Therapeutics Provides Year-end Update
5. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
6. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
7. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Silence Therapeutics Announces Board Changes
10. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
11. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... ALISO VIEJO, Calif. , Nov. 26, 2014 ... today announced that the U.S. Food and Drug ... to its New Drug Application (NDA) for AVP-825. ... of low-dose sumatriptan powder delivered intranasally utilizing a ... In the Complete Response letter, and consistent with ...
(Date:11/26/2014)... 26, 2014 Scott Steiger lives in ... world. As an engineer for the past 20 years, he,s traveled ... military service. He,s been to six of the seven continents. Travel ... - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... has a pretty good idea of what,s required. His ...
(Date:11/26/2014)... 26, 2014 Zynerba Pharmaceuticals , Inc., ... innovative transdermal synthetic cannabinoid treatments, today announced that the ... Healthcare Conference 2014. The conference will be held December ... New York . Zynerba,s Chairman and ... pm on Tuesday, December 2. To listen ...
Breaking Medicine Technology:Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Steiger Has Created the First Pill Case Specifically Designed For Travel 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... complained for years about the mental fog known ... University, researchers have discovered,that injections of N-acetyl cysteine ... breast cancer chemotherapy drugs sometimes induce., In ... issue of the,journal Metabolic Brain Disease, rats were ...
... 4 Cytopia Limited (ASX:,CYT) today announced that ... of CYT997, the company,s novel vascular-disrupting anticancer agent,in ... known as glioblastoma,multiforme (GBM)., The GBM clinical ... in highly,vascular, solid tumor indications for the company ...
Cached Medicine Technology:Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3
(Date:11/27/2014)... Thanksgiving meals can pose a challenge for people who ... Many traditional Thanksgiving dishes -- such as turkey, ... but "when it comes to pies, stuffing, gravy, etc., ... Safta, director of the Gluten and Allergic Digestive Disorders ... Carolina, said in a center news release. "For ...
(Date:11/27/2014)... 2014 Jeffrey Carlini has practiced ... Charlotte area providing audits, reviews, compilations, tax preparation, ... of varying size across numerous industries. Jeff has ... all of their accounting and tax needs. , ... ProAdvisor Program. When asking Mr. Carlini about his ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Two international ... implants procedure will help one person with significant ... Dr. Saj Jivraj and Dr. Mamaly Reshad of the ... Calif., have launched a website devoted to helping dentist ... of the website would be devoted to helping a ...
(Date:11/27/2014)... Washington, DC (PRWEB) November 27, 2014 “LAB.C” ... Report, which features the latest and coolest technology products available ... NewsWatch, conducted the product review and shared with ... cable for iOS and Android devices. , Consumers love portability ... LAB.C. Their Cable Case for the iPhone5 and 5S ...
(Date:11/27/2014)... This is a professional and in ... an overview analysis, the report introduces Insulin basic ... industry overview, policy analysis, and news analysis, etc. ... information on policy, plans for Insulin Market product ... more. , This report also provides ...
Breaking Medicine News(10 mins):Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... Jan. 28 Young Innovations, Inc.,(Nasdaq: YDNT ) ... results with a live and on-demand web cast conference ... Time. A live audio,broadcast of the call will be ... live audio broadcast,will also be available through the Company,s ...
... cough is now a lot easier thanks to a ... been approved by U.S. Food and Drug Administration (FDA) ... test simultaneously detects the most prevalent respiratory viruses, including ... diagnose patients. It was developed by McMaster virologist Dr. ...
... Maintenance Partners for Life Campaign, Reminding People to Properly Care for Both ... ... Engine, HOUSTON, Jan. 28 Jiffy Lube today announces its,first-ever, ... movement in its fight to help eradicate,heart disease. Throughout February and March, ...
... set, British study suggests , , MONDAY, Jan. 28 ... in their free time may be biologically younger ... , "A sedentary lifestyle increases the propensity to ... life expectancy not only by predisposing to aging-related ...
... YORK, Jan. 28 Government, business, civic and,public health ... the creation of aids2031, a global initiative,dedicated to taking ... now in order to,change the face of AIDS by ... was first reported., According to Stefano Bertozzi, chairperson ...
... for detecting and guiding the biopsy of suspicious breast ... half the size of the smallest ones detected by ... The results of initial testing of the PEM/PET system, ... Energys Thomas Jefferson National Accelerator Facility, West Virginia University ...
Cached Medicine News:Health News:McMaster test detects the most prevalent respiratory viruses 2Health News:Jiffy Lube(R) Aims to Raise $1 Million for American Heart Association's Go Red For Women(TM) Movement 2Health News:Jiffy Lube(R) Aims to Raise $1 Million for American Heart Association's Go Red For Women(TM) Movement 3Health News:Jiffy Lube(R) Aims to Raise $1 Million for American Heart Association's Go Red For Women(TM) Movement 4Health News:Jiffy Lube(R) Aims to Raise $1 Million for American Heart Association's Go Red For Women(TM) Movement 5Health News:Sedentary Lifestyle Accelerates Aging 2Health News:New Initiative Launched to Anticipate Future of AIDS 2Health News:New Initiative Launched to Anticipate Future of AIDS 3Health News:Device zeroes in on small breast tumors 2
Double-ended. 3 mm round semi sharp end and 2.75 mm elevator end. Angled 45 degrees....
Double-ended. Designated most popular model or size....
2 mm tip....
Heavy. 7.5 mm curved tip....
Medicine Products: